| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science &Business Off
1 company
Poradosu Enrique is a Chief Science &Business Off at Nuvectis Pharma, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $35.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | NVCT Nuvectis Pharma, Inc. | Chief Science &Business Off | Buy | 2,000 | $4.99 | $9,980.00 | +0.1% | +50.6% | +16.1% | |
| May 10, 2024 | NVCT Nuvectis Pharma, Inc. | Chief Science &Business Off | Buy | 500 | $6.29 | $3,145.00 | - | +6.9% | +40.5% | |
| Mar 27, 2023 | NVCT Nuvectis Pharma, Inc. | Chief Science &Business Off | Buy | 500 | $11.55 | $5,775.00 | - | +37.3% | -31.1% | |
| May 12, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Science &Business Off | Buy | 670 | $15.33 | $10,273.20 | - | -53.2% | -10.5% | |
| Feb 7, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Science &Business Off | Buy | 4,600 | $3.44 | $15,834.00 | +0.2% | +89.4% | +37.0% |